Bayesian Capital Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,200
| Closed | -$470K | – | 790 |
|
|
2024
Q1 | $470K | Buy |
+11,200
| New | +$470K | 0.04% | 452 |
|
|
2022
Q4 | – | Sell |
-7,911
| Closed | -$222K | – | 815 |
|
|
2022
Q3 | $222K | Sell |
7,911
-4,589
| -37% | -$129K | 0.05% | 503 |
|
|
2022
Q2 | $337K | Buy |
+12,500
| New | +$337K | 0.06% | 434 |
|
|
2016
Q2 | – | Sell |
-907
| Closed | -$51K | – | 413 |
|
|
2016
Q1 | $51K | Buy |
+907
| New | +$51K | 0.05% | 330 |
|